Chancroid

Azithromycin 1 g orally in a single dose 

OR 

Ceftriaxone 250 mg IM in a single dose 

OR 

Ciprofloxacin 500 mg orally 2 times/day for 3 days 

OR 

Erythromycin base 500 mg orally 3 times/day for 7 days 

None

Data indicate ciprofloxacin presents a low risk to the fetus during pregnancy but has potential for toxicity during breastfeeding. Alternative drugs should be used if the patient is pregnant or lactating. No adverse effects of chancroid on pregnancy outcome have been reported. 

Persons with HIV infection who have chancroid infection should be monitored closely because they are more likely to experience chancroid treatment failure and to have ulcers that heal slowly. Persons with HIV might require repeated or longer courses of therapy, and treatment failures can occur with any regimen. Data are limited concerning the therapeutic efficacy of the recommended single-dose azithromycin and ceftriaxone regimens among persons with HIV infection.